Ekso Bionics Holdings Inc
EKSO
$1.44
Closing
▲2.86%
1D
▼-42.40%
YTD
Market cap
$25.78M
52 week high
$3.12
52 week low
$0.62
Volume
39,599
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
$25.78M
Analysts' Rating
BUY
Price Target (Mean)
9
Total Analysts
1
P/E
Operating Margin
-63.62%
Beta
1.62
Revenue Growth (Annual)
14.81%
52 week high
$3.12
52 week low
$0.62
Div. Yield
%
EPS Annual Growth
-22.63
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
Ekso Bionics Holdings, Inc. design, develop, and market exoskeleton products. Its exoskeleton technology can be utilized both by able-bodied persons and persons with physical disabilities. Its products include EksoNR is a robotic exoskeleton specifically designed to be used in a rehabilitation setting to progress neuro-rehab patients; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton, and Ekso Indego Personal is a lightweight powered lower limb orthosis. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, and in some cases, to walk again; provides ambulation assistance in home and community settings for individuals with certain SCI levels; assist individuals with a broad range of upper extremity impairments, and allow industrial workers to perform difficult repetitive work for extended periods.
